Results 61 to 70 of about 185,739 (209)

Thyroid carcinoma with atypical metastasis to the pituitary gland and unexpected postmortal diagnosis

Endocrinology, Diabetes & Metabolism Case Reports, 2020
Papillary thyroid gland carcinoma is the most common type of malignancy of the endocrine system. Metastases to the pituitary gland have been described as a complication of papillary thyroid cancer in few reported cases since 1965. We report the case of a
Anna Popławska-Kita, Marta Wielogórska, Łukasz Poplawski, Katarzyna Siewko, Agnieszka Adamska, Piotr Szumowski, Piotr Myśliwiec, Janusz Myśliwiec, Joanna Reszeć, Grzegorz Kamiński, Janusz Dzięcioł, Dorota Tobiaszewska, Małgorzata Szelachowska, Adam Jacek Krętowski   +13 more
doaj   +1 more source

Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors

Journal of International Medical Research, 2019
Objective The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) have recently been introduced as prognostic markers of thyroid cancer and strong inflammatory markers.
Aziz Ari, Feray Gunver
doaj   +1 more source

Case report: Lymph node metastases of breast cancer and thyroid cancer encountered in axilla

Frontiers in Oncology, 2022
Occurrences of breast cancer and thyroid cancer metachronously or synchronously are common for women, but axillary lymph node metastasis from both cancers is rarely seen.
Rihan Li, Rihan Li, Qingfu Zhang, Dongdong Feng, Dongdong Feng, Feng Jin, Siyuan Han, Siyuan Han, Xinmiao Yu, Xinmiao Yu   +9 more
doaj   +1 more source

An allelotype of papillary thyroid cancer [PDF]

International Journal of Cancer, 1996
Although papillary carcinoma accounts for approximately 70% of all thyroid cancers, preliminary studies of allelic loss have thus far not identified any areas of chromosomal deletion. We evaluated 30 papillary thyroid carcinomas for chromosomal loss/allelic imbalance by testing at least 2 microsatellite markers from every autosomal arm.
J A, Califano, M M, Johns, W H, Westra, M N, Lango, D, Eisele, M, Saji, M A, Zeiger, R, Udelsman, W M, Koch, D, Sidransky   +9 more
openaire   +2 more sources

Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report

Frontiers in Oncology, 2022
Little is known about the efficacy of alectinib for papillary thyroid cancer with STRN-ALK fusion. A 64-year-old female presented with metastatic papillary thyroid cancer, widespread to lungs, mediastinal lymph nodes and brain 20 years after surgery ...
Lucheng Zhu, Lucheng Zhu, Shenglin Ma, Bing Xia, Bing Xia   +4 more
doaj   +1 more source

Hashimoto's Thyroiditis and Papillary Thyroid Cancer [PDF]

Journal of Korean Thyroid Association, 2014
The association of Hashimoto’s thyroiditis (HT) with papillary thyroid cancer (PTC) has been still under debate. Some suggest that these two are positively correlated, whereas other studies report no relationship. We performed a systematic literature review of original studies to investigate the correlation between HT and PTC. The existing data provide
openaire   +1 more source

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

BMC Cancer, 2019
Treatment options for advanced thyroid cancer refractory to standard therapies are limited. The safety and efficacy of pembrolizumab were evaluated in patients with advanced differentiated thyroid cancer expressing programmed death ligand 1 (PD-L1 ...
J. Mehnert, A. Varga, M. Brose, R. Aggarwal, Chia‐Chi Lin, A. Prawira, F. D. De Braud, K. Tamura, T. Doi, S. Piha-Paul, J. Gilbert, S. Saraf, P. Thanigaimani, Jonathan D. Cheng, B. Keam   +14 more
semanticscholar   +1 more source

Local recurrence of papillary thyroid cancer [PDF]

Expert Review of Endocrinology & Metabolism, 2015
Management of advanced papillary thyroid cancer (PTC >10 mm) is changing its focus. Mortality was the main outcome measure for patients treated before the 90s. In the past two decades, however, most patients diagnosed with PTC belong to the very low risk of death group.
openaire   +2 more sources

Papillary thyroid cancer case masked by subacute thyroiditis [PDF]

Arquivos Brasileiros de Endocrinologia & Metabologia, 2014
Subacute thyroiditis (SAT) association with thyroid carcinoma has been rarely reported in the literature. We present a patient with SAT and papillary thyroid cancer that was suspected by ultrasonographic evaluation (US) following SAT treatment. A fifty-four-year old female patient referred to our department due to tachycardia, jitteriness and pain in ...
Bekir, Ucan, Tuncay, Delibasi, Erman, Cakal, Muyesser Sayki, Arslan, Nujen Colak, Bozkurt, Taner, Demirci, Mustafa, Ozbek, Mustafa, Sahin   +7 more
openaire   +2 more sources

Pathophysiology of tumor progression and possibilities of using polarization biomedical optics methods in the diagnosis of papillary thyroid cancer

Mìžnarodnij Endokrinologìčnij Žurnal
Background. Clinical diagnosis of papillary thyroid cancer usually occurs at the stage of tumor progression accompanied by intensive processes of growth, invasion, formation of blood vessels to provide blood supply to the tumor, the structure and ...
Yu.Ye. Rohovyi, O.V. Bilookyi, O.H. Ushenko, V.V. Bilookyi   +3 more
doaj   +1 more source